JDD June 2024 Issue Highlights
In this June edition of the Journal of Drugs in Dermatology (JDD), we're excited to showcase a selection of groundbreaking research and expert insights that delve into the latest advancements and treatments in dermatology. From innovative acne scar therapies to in-depth analyses of topical acne treatments, this month's featured articles provide a comprehensive overview of current dermatological …
In this June edition of the Journal of Drugs in Dermatology (JDD), we're excited to showcase a selection of groundbreaking research and expert insights that delve into the latest advancements and treatments in dermatology. From innovative acne scar therapies to in-depth analyses of topical acne treatments, this month's featured articles provide a comprehensive overview of current dermatological … 
The 2023 Skin of Color Update in New York City featured a comprehensive discussion on the evolving landscape of treating acne, with a particular focus on medical and procedural approaches. Attendees had the unique opportunity to hear Dr. Valerie Callendar, professor of dermatology at Howard University College of Medicine in Washington, DC, and Dr. Andrew Alexis, Professor of Clinical Dermatology … 
With a special focus on the topic of psoriasis, check out highlights from the August issue of the Journal of Drugs in Dermatology (JDD) straight from the JDD Editor’s desk:
Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in Psoriasis delves into the expert guidance provided by the Psoriasis Expert Group (PEG), encompassing nine crucial statements that offer com … 
Linda Stein Gold, Director of Dermatology Clinical Research at Henry Ford Health System, lead us through “Acne across the ages” at the 17th Annual Women’s and Pediatric Dermatology Seminar. She busted through several acne myths, which are easily debunked with new acne medications:
Clascoterone 1% cream: it reduces sebum production in the skin! Similar to spironolactone, it is an anti-andr … 
Clascoterone cream is a novel topical therapeutic agent used to treat acne vulgaris through androgen inhibition. Other androgen inhibitors such as combined oral contraceptive pills and off-label spironolactone can lead to some unwanted side effects such as feminization, gynecomastia, and erectile dysfunction, making them unsuitable for male patients. Unlike other androgen inhibitors used to manage … 